BCM
MDCO

BlueCrest Capital Management’s Medicines Co MDCO Stock Holding History

BlueCrest Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,543
Closed -$323K – 1229
2019
Q1 		$323K Buy
+11,543
New +$272K 0.01% 668
2018
Q1 		– Sell
-9,264
Closed -$253K – 1704
2017
Q4 		$253K Sell
9,264
-26,203
-74% -$807K 0.01% 664
2017
Q3 		$1.31M Buy
+35,467
New +$1.31M 0.05% 330

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BlueCrest Capital Management's MDCO Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Medicines Co (MDCO) in Q2 2019, closing a stake of 11,543 shares — an estimated $323K sold.

BlueCrest Capital Management first reported a position in MDCO in Q3 2017 and held it in 3 quarters. The position peaked at $1.31M in Q3 2017. 228 funds tracked by Wall St. Rank hold MDCO as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Medicines Co position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 11,543 Medicines Co shares in Q2 2019, an estimated $323K.
  • BlueCrest Capital Management first reported a position in Medicines Co in Q3 2017 and held it in 3 quarters.
  • BlueCrest Capital Management's Medicines Co position peaked at $1.31M in Q3 2017.
  • 228 funds tracked by Wall St. Rank held Medicines Co as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.